Lundbeck Unveils Depression Education Program In China
This article was originally published in PharmAsia News
Executive Summary
Healthcare experts estimate a large share of China’s depression population has never been diagnosed thanks to low recognition of the disease, creating a potentially huge population of patients who could benefit from treatment.
You may also be interested in...
Lundbeck Establishes Shanghai Research Center To Find More Chinese Partnerships
Danish pharma Lundbeck A/S announced Oct. 14 that it established a research center in Shanghai to increase its footprint in the largest emerging market and better position itself for more partnerships in China
China’s Simcere Receives Buyout Offer From Its Chairman, But Could Delisting Be A Negative Overseas?
Simcere would join Chinese firms 3SBio and ShangPharma in pulling out of the U.S. stock market.
China’s New Good Supply Practices Regs Require Electronic Barcodes; Raise Bar To Entry
The Ministry of Health’s GSP regulation tries to plug a hole in supply chain security through tighter IT controls, such as requiring electronic barcodes.